Kimberly-Clark's North American sales saw a 1.1% organic growth with slight volume increases, although supply chain disruptions somewhat affected profits. The company navigated these headwinds through ...

Kimberly-Clark forecast annual adjusted profit growth ahead of Wall Street estimates and reported better-than-expected quarterly sales on Tuesday as the Kleenex tissue maker benefited from a ...

UBS analyst Peter Grom raised the firm’s price target on Kimberly-Clark (KMB) to $134 from $132 and keeps a Neutral rating on the shares.